To include your compound in the COVID-19 Resource Center, submit it here.
INDICATION: Breast cancer
Cell culture studies suggest inhibiting NEK9 or MAP2K4 could help treat PI3K inhibitor-resistant triple-negative breast cancer (TNBC).
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury